Health Utility Estimation Based on Parenteral Support Days for Adult Patients With Short Bowel Syndrome and Intestinal Failure in Korea
Speaker(s)
Sim H1, Moon JS2, Park YS3, Heo E4, Chun YS4, Ku H5, Chung JH6
1NDnex, Seoul, 41, South Korea, 2Seoul National University College of Medicine, Seoul, Korea, Republic of (South), 3Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South), 4Takeda Pharmaceuticals Korea Co., Ltd., Seoul, Korea, Republic of (South), 5NDnex, Gwangmyeong-si, Gyeonggi-do, Korea, Republic of (South), 6Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
Presentation Documents
OBJECTIVES: This study aimed to estimate the health utility weights associated with the frequency of weekly parenteral support (PS) in adult patients with short bowel syndrome and intestinal failure (SBS-IF), as perceived by the general Korean population.
METHODS: We developed scenarios depicting health states of adult SBS-IF patients based on PS frequency using previous studies, in-depth interviews with 9 SBS-IF patients, and clinical expert reviews. A general population survey in Korea measured health utility using the EQ-5D, Visual Analogue Scale (VAS), and Time Trade-Off (TTO) methods. Mean utility values were calculated across weekly PS days groups. Subgroup comparisons were performed using t-tests and ANOVA. Multilevel analysis addressed repeated measures and controlled for sociodemographic factors.
RESULTS: The analysis included 179 participants from the general Korean population. Utility scores, as measured by EQ-5D, VAS, and TTO, demonstrated a negative correlation with increasing PS days in SBS-IF patients. The mean utility value for "0 days on PS" was the highest (EQ-5D: 0.808, VAS: 0.689, TTO: 0.874) and these scores progressively decreased with each additional PS day. The mean utility value for "7 days on PS" was the lowest (EQ-5D: 0.117, VAS: 0.180, TTO: 0.272). After adjusting for covariates, PS frequency remained a significant predictor of utility values (P < 0.001).
CONCLUSIONS: This study revealed a significant increase in health-related quality of life (HRQoL) for adult SBS-IF patients with decreasing PS frequency. Interventions to minimize the number of PS days hold promise for substantially improving HRQoL in this patient population.
Code
PCR26
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities
Disease
Gastrointestinal Disorders, Rare & Orphan Diseases